Clinical Professor of Medicine, UCLA
Cardiology
Dr. David S. Cannom, MD
|
|
Give Review
David Cannom works in the field of Cardiology. He went to University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He over the years received 6 awards: "America's Top Doctors", "Top Doctors:LA Area", "Top Doctors:Southern California", "Super Doctor", "Fellow (FACC)" and "Top MD". David Cannom has written publications. He has 38 publications published with PubMed. The lastest paper is: 'Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriat...' David Cannom accepts Medicare.
Publications
- Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriat...
- Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure.
- Amiodarone reduces the amount of ablation during catheter ablation for persistent Atrial fibrillation.
- Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.
- Biphasic versus Monophasic Cathodal Ventricular Pacing.
- QRS Axis and the Benefit of Cardiac Resynchronization Therapy in Patients with Mildly Symptomatic Heart Failure Enrolled in MADIT-CRT.
- Introduction: Syncope issue.
- Emotional stressors trigger cardiovascular events.
- Unusual Substrate Underlying Brugada Syndrome and Early Repolarization Syndrome Revealed in Unusual Circadian and Seasonal Patterns.
- 2011 ACCF/AHA/HRS focused update on the management of patients with Atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundati...
- Comparison of the point-by-point versus catheter dragging technique for curative radiofrequency ablation of Atrial fibrillation.
- Management of Atrial fibrillation: translating clinical trial data into clinical practice.
- The Use of Balloon Atrial Septostomy to Facilitate Difficult Transseptal Access in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
- Arrhythmogenic right ventricular Cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.
- The role of electrophysiologic studies in dilated Cardiomyopathy: definitive results from the DEFINITE trial.
- The Fidelis recall: how much pressure can the ICD world bear?
- Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequelae why it is important and how it works.
- Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices.
- Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study.
- Validation and clinical application of time-frequency analysis of Atrial fibrillation electrocardiograms.
- Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators.
- Patterns and predictors of warfarin use in patients with new-onset Atrial fibrillation from the FRACTAL Registry.
- Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol.
- Relationship of the implantable cardioverter defibrillator and Chronic resynchronization therapy: the perfect marriage?
- Prevention of sudden cardiac death.
- First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia.
- Primary ventricular Fibrillation cannot be buried; it never died.
- Rules of evidence: CMS and primary prevention of sudden cardiac death in systolic Heart failure.
- Determinants and prognostic significance of immediate Atrial fibrillation recurrence following cardioversion in patients undergoing pulmonary vein isolation.
- Effectiveness of catheter ablation for coexisting Atrial fibrillation and Atrial flutter.
- Current role of device therapy to reduce sudden cardiac death in Heart failure.
- Prevention of primary ventricular fibrillation in Acute myocardial infarction with prophylactic lidocaine.
- The evolution of the implantable cardioverter defibrillator.
- Evolution of the implantable cardioverter defibrillator.
- New device indications: impact on the individual electrophysiology (EP) practitioner in a predominantly managed care environment.
- Implantable cardioverter defibrillator trials: what's new?
- History of Syncope in the cardiac literature.
Schools
University Of Minnesota Medical School
Yale New Haven Hospital
Stanford University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Ectasia
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Whole HealthPrimeCare California HMO
- Power Select HMO
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Guided Access HMO
- Pathway X Tiered Direct Access
- Priority Select HMO
- Select Plus HMO
- Access Plus Savenet
- Basic PPO
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Coventry Health Care
- Delta Health System
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Blue & Gold HMO
- Community Care Network HMO
- Employer Group HMO
- Individual and Family PPO
- Medicare Advantage PFFS
- SmartCare HMO
- WholeCare Network HMO
- HealthPartners
- Humana
- Kaiser Permanente
- LACare
- Mail Handlers Benefit Plan (MHBP)
- MedHealthInsurance
- Medicaid
- Medicare MCR
- Meritain Health
- Molina
- Heritage Signature
- Principal Life
- Tricare
- TriWest Champus
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- America's Top Doctors
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
- Fellow (FACC)
- Top MD
Education
-
Stanford University -
Yale-New Haven Hospital -
University of Minnesota Medical School
Hospital
-
Good Samaritan Hospital -
California Hospital Medical Center -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1346234952 | |
| NPPES Provider LastName | CANNOM | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 900174807 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 9218.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346234952 |
| Last Name Of The Provider | CANNOM |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Vivian Y. Mo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jashdeep S. Dhoot, MD |
|
|
Dr. Fabian Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prashant S. Patel, MD |
|
|
Dr. Ajay Yadlapati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kimberly C. Atianzar, MD |
|
|
Dr. Robert Cole, MD |
|
|
Dr. Jayson A. Morgan, MD |
|
|
Dr. Allison E. Lowe, MD |
|
|
Mary K. McCloy, NP |